Echosens Launches Collaborative Relationship with Healthy Trucking of America: Improves Liver Health, Safety, and Productivity for Nationwide Professional Drivers


WALTHAM, Mass .– (COMMERCIAL THREAD) –Echosens, a high-tech company offering the FibroScan family of products, announces its collaborative relationship with America’s Healthy Trucking (HTA), the leading authority on health and wellness matters for American truckers. The goal of the collaboration is to proactively address liver health among its 770,000 active fleets in the United States, including independent owner / operators and fleet operators representing 7 million highly insured professional drivers. The non-invasive, rapid and painless FibroScan exam to accurately assess liver health is expected to become a key success factor in mitigating the risk and halting the progression of fatty liver disease, fibrosis or cirrhosis of the liver in drivers . These conditions are inextricably bound metabolic syndrome and obesity and can result from work-related conditions including long hours behind the wheel with limited opportunities for physical activity, healthy eating, and regular work and sleep schedules.

Bill Gordon, founder and CEO of HTA, underlines this collaboration with Echosens within the framework of the HTA ”Transition from 2021 to better health ” campaign, saying, “Improving the health of professional drivers is vital to the longevity of the trucking industry and the safety of all road users. We are redoubling our efforts in the prevention, education and early detection of liver disease, with broader initiatives to offer truck drivers and support staff free health coach assistance and change programs lifestyle for a number of chronic disorders. Unfortunately, one in three drivers have symptoms of prediabetes and are unaware of it, a factor that influences the development of liver disease.

He adds that this collaboration also supports liver and metabolic health through early identification and driver engagement with HTA health coaches and partners. This extensive program supports a healthier lifestyle to ensure professional drivers continue to pass the semi-annual medical examination conducted by licensed forensic pathologists and required by the Department of Transportation to maintain a commercial driver’s license or risk losing their earnings -bread.

According to HTA, 54.2% of members report being obese, followed closely by 47.2% reporting liver problems and 32.8% reporting diabetes. Since 2016, HTA has had an established relationship with the CDC in prediabetes treatment and weight management programs and has implemented National Diabetes Prevention Program (NDPP) outreach programs to more than 200,000 fleets across the United States to improve the health of professional drivers.

Jon Gingrich, CEO of Echosens North America, “We are delighted to join forces with HTA and play an important role in improving the health of frequent professional drivers nationwide. Even modest lifestyle changes – including diet and exercise – can have a big impact, with even 3% to 5% weight loss documented to improve liver health. FibroScan is easy to implement and provides a valuable tool for early detection, monitoring, education and patient engagement.

About Echosens

Echosens, the developer of FibroScan®, is an innovative, high-tech company providing a full range of products and services to assist physicians in their assessment and management of patients with chronic liver disease. FibroScan is backed by over 2,500 peer-reviewed publications and reviews are covered by Medicare, Medicaid, and many insurance plans. For more information, please visit

About Healthy Trucking of America

Since 1997, Healthy Trucking of America (HTA) has had the sole focus of striving to improve the health and well-being of truck drivers, both independent owners / operators and fleet drivers. HTA is the first national organization ever formed to tackle the lack of good health among the professional driver population in the country. HTA integrates information on specific diseases and conditions for awareness campaigns, free screenings and models of care solution for transportation industries. More information at


Comments are closed.